The structures of three metabolites of the algal hepatotoxin okadaic acid produced by oxidation with human cytochrome P450
- PMID: 22608922
- PMCID: PMC3601775
- DOI: 10.1016/j.bmc.2012.04.046
The structures of three metabolites of the algal hepatotoxin okadaic acid produced by oxidation with human cytochrome P450
Abstract
Four metabolites of okadaic acid were generated by incubation with human recombinant cytochrome P450 3A4. The structures of two of the four metabolites have been determined by MS/MS experiments and 1D and 2D NMR methods using 94 and 133 μg of each metabolite. The structure of a third metabolite was determined by oxidation to a metabolite of known structure. Like okadaic acid, the metabolites are inhibitors of protein phosphatase PP2A. Although one of the metabolites does have an α,β unsaturated carbonyl with the potential to form adducts with an active site cysteine, all of the metabolites are reversible inhibitors of PP2A.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
The algal hepatoxoxin okadaic acid is a substrate for human cytochromes CYP3A4 and CYP3A5.Toxicon. 2010 Feb-Mar;55(2-3):325-32. doi: 10.1016/j.toxicon.2009.08.007. Epub 2009 Aug 20. Toxicon. 2010. PMID: 19699225 Free PMC article.
-
Differences in metabolism of the marine biotoxin okadaic acid by human and rat cytochrome P450 monooxygenases.Arch Toxicol. 2016 Aug;90(8):2025-36. doi: 10.1007/s00204-015-1591-9. Epub 2015 Sep 15. Arch Toxicol. 2016. PMID: 26374342
-
CYP3A4 activity reduces the cytotoxic effects of okadaic acid in HepaRG cells.Arch Toxicol. 2014 Aug;88(8):1519-26. doi: 10.1007/s00204-014-1206-x. Epub 2014 Feb 7. Arch Toxicol. 2014. PMID: 24504163
-
A molecular modeling analysis of the binding interactions between the okadaic acid class of natural product inhibitors and the Ser-Thr phosphatases, PP1 and PP2A.Bioorg Med Chem. 1997 Sep;5(9):1751-73. doi: 10.1016/s0968-0896(97)00145-4. Bioorg Med Chem. 1997. PMID: 9354231 Review.
-
Okadaic acid: the archetypal serine/threonine protein phosphatase inhibitor.Curr Med Chem. 2002 Nov;9(22):1939-80. doi: 10.2174/0929867023368791. Curr Med Chem. 2002. PMID: 12369865 Review.
Cited by
-
Multi-omics analysis reveals metabolism of okadaic acid in gut lumen of rat.Arch Toxicol. 2022 Mar;96(3):831-843. doi: 10.1007/s00204-021-03219-5. Epub 2022 Jan 16. Arch Toxicol. 2022. PMID: 35037095
-
A Review of In Situ Methods-Solid Phase Adsorption Toxin Tracking (SPATT) and Polar Organic Chemical Integrative Sampler (POCIS) for the Collection and Concentration of Marine Biotoxins and Pharmaceuticals in Environmental Waters.Molecules. 2022 Nov 15;27(22):7898. doi: 10.3390/molecules27227898. Molecules. 2022. PMID: 36431996 Free PMC article. Review.
-
Contribution of Mass Spectrometry to the Advances in Risk Characterization of Marine Biotoxins: Towards the Characterization of Metabolites Implied in Human Intoxications.Toxins (Basel). 2023 Jan 22;15(2):103. doi: 10.3390/toxins15020103. Toxins (Basel). 2023. PMID: 36828418 Free PMC article. Review.
-
Oral toxicity of okadaic acid in mice: study of lethality, organ damage, distribution and effects on detoxifying gene expression.Toxins (Basel). 2013 Nov 8;5(11):2093-108. doi: 10.3390/toxins5112093. Toxins (Basel). 2013. PMID: 24217398 Free PMC article.
-
In Vitro Interactions between Okadaic Acid and Rat Gut Microbiome.Mar Drugs. 2022 Aug 30;20(9):556. doi: 10.3390/md20090556. Mar Drugs. 2022. PMID: 36135745 Free PMC article.
References
-
- Reguera B, Pizarro G. In: Seafood and freshwater toxins: Pharmacology physiology and detection. 2. Botana L, editor. Taylor & Francis; Londres: 2008. pp. 257–284. Chapter 15.
-
- Swanson KM, Flewelling LJ, Byrd M, Nunez A, Villareal TA. Harmful Algae. 2010;9:190.
-
- Deeds JR, Wiles K, Heideman GB, White KD, Abraham A. Toxicon. 2010;55:1138. - PubMed
-
- Le Hégarat L, Puech L, Fessard V, Poul JM, Dragacci S. Mutagenesis. 2003;18:293. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources